State of New Jersey Common Pension Fund D Acquires New Position in Liquidia Corporation $LQDA

State of New Jersey Common Pension Fund D bought a new position in Liquidia Corporation (NASDAQ:LQDA) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 20,569 shares of the company’s stock, valued at approximately $709,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. NewEdge Advisors LLC purchased a new stake in shares of Liquidia in the second quarter valued at approximately $25,000. Skandinaviska Enskilda Banken AB publ acquired a new position in Liquidia during the third quarter worth $30,000. FNY Investment Advisers LLC purchased a new stake in Liquidia in the 3rd quarter valued at $34,000. Tower Research Capital LLC TRC grew its holdings in Liquidia by 281.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after buying an additional 4,927 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in shares of Liquidia in the 3rd quarter worth $170,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Trading Up 25.6%

Shares of LQDA stock opened at $53.13 on Tuesday. Liquidia Corporation has a 1-year low of $11.85 and a 1-year high of $53.93. The firm has a market cap of $4.72 billion, a PE ratio of -64.01 and a beta of 0.41. The company has a 50-day moving average of $37.66 and a two-hundred day moving average of $35.04. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The business had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. Liquidia’s revenue for the quarter was up 4187.1% compared to the same quarter last year. On average, analysts predict that Liquidia Corporation will post 1.75 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently weighed in on LQDA. Wall Street Zen raised shares of Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Jefferies Financial Group reaffirmed a “buy” rating and set a $60.00 target price on shares of Liquidia in a research note on Monday. Wells Fargo & Company boosted their target price on shares of Liquidia from $44.00 to $51.00 and gave the company an “overweight” rating in a report on Monday, March 23rd. Oppenheimer increased their price target on shares of Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a research note on Thursday, March 12th. Finally, Lifesci Capital upgraded shares of Liquidia to a “strong-buy” rating in a report on Thursday, March 5th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Sell rating to the company. According to data from MarketBeat, Liquidia has an average rating of “Moderate Buy” and a consensus price target of $46.78.

Key Stories Impacting Liquidia

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia reported first-quarter 2026 earnings of $0.52 per share, well above estimates, while revenue of $132.87 million also topped forecasts. The company said YUTREPIA generated about $130 million in net product sales, helping deliver a third consecutive quarter of profitability and another cash increase. Article: Liquidia Corporation Reports First Quarter 2026 Financial Results
• Positive Sentiment: Needham & Company raised its price target on Liquidia to $70 from $54 and reiterated a buy rating, signaling confidence in further upside after the earnings beat. Article: Needham price target increase
• Positive Sentiment: BTIG Research also lifted its price target to $59 from $50 and kept a buy rating, adding to the bullish analyst momentum around the stock. Article: BTIG price target increase
• Neutral Sentiment: Liquidia’s earnings call transcript and presentation may provide more detail on YUTREPIA sales, launch trends, and upcoming pipeline programs, but they are not new catalysts by themselves. Article: Q1 2026 Earnings Call Transcript Article: Q1 2026 Results Presentation
• Neutral Sentiment: The company also disclosed a short-interest update showing 0 shares reported short, which does not appear to be a meaningful market driver. Article: Short interest update
• Negative Sentiment: Recent insider selling by the CEO could create some caution for investors, even though it does not offset the stronger operational news. Article: Insider selling

Insider Activity at Liquidia

In other news, CAO Dana Boyle sold 1,576 shares of the firm’s stock in a transaction on Monday, April 27th. The stock was sold at an average price of $37.78, for a total transaction of $59,541.28. Following the completion of the transaction, the chief accounting officer directly owned 175,342 shares in the company, valued at $6,624,420.76. This trade represents a 0.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Roger Jeffs sold 25,000 shares of Liquidia stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $42.09, for a total value of $1,052,250.00. Following the completion of the sale, the chief executive officer directly owned 1,348,095 shares of the company’s stock, valued at $56,741,318.55. The trade was a 1.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 628,820 shares of company stock worth $24,801,008 over the last quarter. Company insiders own 25.60% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).